
Houssein Safa, MD
@hsafamd
Heme/Onc fellow @BCMHouston @BCMHemeonc. Postdoc alumnus via @MDandersonnews. A ♋️ treating cancer. Despiser of windowless rooms. Views are my own.
ID: 264227837
http://bit.ly/2Kc9c1M 11-03-2011 15:15:34
2,2K Tweet
3,3K Followers
900 Following

The future of oncology is bright! Inspiring to meet with superstar fellow Houssein Safa, MD at #ASCO24



Coming in hot from NYC to Houston BCM Hematology-Oncology Fellowship!! Fellow of The Quarter Award right off the bat: ✅ Guess that means I can start slacking now .. right Dr. Martha Mims?!!


🚨Out now Clinical Cancer Research! We demonstrate accurate non-invasive detection of small cell transformation in EGFRm lung adenocarcinoma through epigenomic cfDNA profiling! Led by @Cbmeador Xintao & guided by Jacob Berchuck #MattFreedman Dana-Farber Mass General Cancer Center doi.org/10.1158/1078-0…


Even in a busy Monday heme clinic, our fellows and attendings find a moment to pose for photos! We’re so proud of our freshly minted PGY-4, Houssein Safa, MD, for winning one of the Fellows of the Quarter awards. Come join our fellowship we promise to recognize all your achievements!

It's true that we just said goodbye to our graduating fellows, but we also welcomed a new wonderful class of 11 fellows! Excited to see how these bright minds make cancer history. Say hi to the Class of 2027! BCMHouston



Sunday AM rounds on the inpatient service .. Dr. Martha Mims spearheading team hematology 💪🏻 Leukemias won’t stand a chance



‼️🚨The best current evidence on the role of HPV in Penile Cancer: A Meta-Analysis by our group Moffitt Cancer Center Philippe spiess Anna Giuliano Curtis Pettaway, MD Majd Al Assaad, MD ACS National HPV Vaccination Roundtable Houssein Safa, MD NCCC HPV Action Network Massachusetts HPV Coalition HPV-cancer.org doi.org/10.6004/jnccn.…



‼️🚨A Contemporary Review on Immune-Based and Novel Therapies in Variant Histology Renal Cell Carcinomas by ⭐️Moffitt Hematology/Oncology Fellowship Justin Miller #JeffJhonson Chris Guske Moffitt Cancer Center mdpi.com/2072-6694/17/2…


Congrats @jadchahoud on the terrific talk👉Ab#4515 ASCO #ASCO25 👉Phase 1b STELLAR-002 study of zanzalintinib + nivo +/- relatlimab in pts w/ ccRCC #kidneycancer 👉ORR 63% w/ zanza+nivo (adding relatlimab does not help), key takeaway👇 OncoAlert UroToday.com @KidneyCAN Sumanta K. Pal, MD, FASCO


🚨 Solid tumor CAR T -> RCC? At #ASCO25, we #SamerSrour, Sumanta K. Pal, MD, FASCO present updated results from the TRAVERSE study of off-the-shelf CD70 CAR T cell therapy (ALLO-316) in mRCC: ✅ 31% ORR in heavily pretreated ccRCC ✅ Durable responses up to 1 year Moffitt Cancer Center MD Anderson Cancer Center



🎙️ Excited to launch our new LungCancerRx 🫁💊 podcast in partnership with Oncology News Central this Friday, 6/13! We kick off with a powerful first episode featuring Jill Feldman from EGFR Resisters. Tune in on #AppleMusic and #Spotify. Don’t miss it! #LungCancer #Oncology #LCSM